Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel
Curr Med Res Opin. 2021 Mar 24:1. doi: 10.1080/03007995.2021.1908245. Online ahead of print.ABSTRACTWith current COVID-19 vaccine demand outweighing supply and the emergency authorization/rollout of three novel vaccines in the United States, discussions continue regarding fair prioritization among various groups for this scarce resource. The U.S. federal government's recommended vaccination schedule, meant to assist states with vaccine allocation, demonstrates fair ethical considerations, however, difficulties remain comparing various groups to determine fair vaccine access and distribution. Although strides have been taken to analyse risks versus benefits of early vaccination across certain high-risk populations, prioritizing vulnerable populations versus essential workers remains challenging for multiple reasons. Similarly, as COVID-19 vaccine allocation and distribution continues in the U.S. and in other countries, topics that require continued consideration include sub-prioritization among currently prioritized groups, prioritization among vulnerable groups disproportionately affected by the COVID-19 pandemic, like ethnic minorities, and holistic comparisons between groups who might receive various and disparate benefits from vaccination. Although all current COVID-19 vaccines are emergency authorization use only and a vaccine-mandate would be considered only once these vaccines are licensed by the U.S. Food and Drug Administration, future vaccination policies require tim...
Source: Current Medical Research and Opinion - Category: Research Authors: Katarina Hughes Vinaya Gogineni Chandani Lewis Abhishek Deshpande Source Type: research
More News: COVID-19 | Emergency Medicine | Environmental Health | Food and Drug Administration (FDA) | Government | Medical Ethics | Pandemics | Research | USA Health | Vaccines